Studies have demonstrated that the inhibition of LAT1, but not 4F2hc, leads to significant tumor growth arrest, highlighting the role of LAT1 in cancer cell growth and its potential as a molecular target for anticancer therapeutics [124]. This evidence concerns the gene SLC7A5 and neoplasm.